Atea Pharmaceuticals Ownership | Who Owns Atea Pharmaceuticals?

Atea Pharmaceuticals Ownership Summary

Atea Pharmaceuticals is owned by 66.55% institutional investors, 9.99% insiders, and 23.46% retail investors. Blackrock is the largest institutional shareholder, holding 10.87% of AVIR shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.56% of its assets in Atea Pharmaceuticals shares.

AVIR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Atea Pharmaceuticals	66.55%	9.99%	23.46%
Sector	Healthcare Stocks	57.43%	9.41%	33.16%
Industry	Biotech Stocks	69.02%	8.92%	22.06%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	9.12M	10.87%	$30.19M
Blackrock funding, inc. /de	9.06M	10.73%	$30.36M
Bml capital management	7.61M	9.01%	$25.49M
Fmr	6.43M	7.61%	$21.52M
Tang capital management	4.79M	5.67%	$16.04M
Vanguard group	4.67M	5.53%	$15.63M
Ecor1 capital	3.34M	3.96%	$11.19M
Bain capital life sciences investors	2.49M	2.94%	$8.33M
Geode capital management	1.92M	2.27%	$6.42M
State street	1.79M	2.12%	$5.98M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bml capital management	7.61M	15.83%	$25.49M
Tang capital management	4.79M	1.06%	$16.04M
Bain capital life sciences investors	2.49M	0.98%	$8.33M
Cm management	300.00K	0.90%	$1.00M
Almitas capital	752.00K	0.55%	$2.52M
Ecor1 capital	3.34M	0.42%	$11.19M
Newtyn management	580.00K	0.34%	$1.94M
Auour investments	177.00K	0.19%	$541.62K
Adar1 capital management	110.00K	0.07%	$368.50K
Marquette asset management	47.17K	0.03%	$158.01K

Top Buyers

Holder	Shares	% Assets	Change
Bml capital management	7.61M	15.83%	958.31K
Jpmorgan chase	409.26K	0.00%	314.01K
Newtyn management	580.00K	0.34%	200.00K
Dimensional fund advisors lp	977.47K	0.00%	183.84K
Tang capital management	4.79M	1.06%	181.85K

Top Sellers

Holder	Shares	% Assets	Change
Ecor1 capital	3.34M	0.42%	-2.10M
Almitas capital	752.00K	0.55%	-632.53K
Acuitas investments	-	-	-323.54K
Fmr	6.43M	0.00%	-193.07K
Vanguard group	4.67M	0.00%	-184.36K

New Positions

Holder	Shares	% Assets	Change	Value
Adar1 capital management	110.00K	0.07%	110.00K	$368.50K
Bnp paribas arbitrage, snc	96.43K	0.00%	96.43K	$323.05K
Hightower advisors	50.09K	0.00%	50.09K	$167.79K
Bridgeway capital management	33.30K	0.00%	33.30K	$111.56K
Millennium management	22.51K	-	22.51K	$75.39K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-15.00
Federation des caisses desjardins du quebec	-24.00
Capital performance advisors llp	-31.00
Smartleaf asset management	-46.00
Colonial trust advisors	-46.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	105	-2.78%	56,185,130	-2.97%	66	1.41%	52	-1.89%	30	3.45%
Sep 30, 2024	108	1.89%	57,907,511	2.15%	68	1.50%	54	14.89%	28	-24.32%
Jun 30, 2024	106	-8.62%	56,687,791	4.35%	67	1.59%	47	-11.32%	37	-5.13%
Mar 31, 2024	116	3.57%	54,324,574	-1.24%	65	1.50%	53	-5.36%	39	34.48%
Dec 31, 2023	112	-8.20%	55,005,563	-3.18%	65	1.42%	56	12.00%	29	-27.50%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	3.85M	4.56%	16.00K
Fidelity Growth Compy Commingled Pl O	3.73M	4.42%	23.40K
Vanguard Total Stock Mkt Idx Inv	2.36M	2.80%	-
iShares Russell 2000 ETF	2.00M	2.36%	-39.11K
Vanguard Institutional Extnd Mkt Idx Tr	1.08M	1.28%	862.00
Fidelity Growth Company Fund	940.20K	1.11%	-19.23K
Fidelity Small Cap Index	763.08K	0.90%	-5.56K
Fidelity Growth Company K6	722.54K	0.86%	-15.68K
iShares Russell 2000 Value ETF	716.35K	0.85%	-1.47K
BlackRock Advantage Small Cap Core Instl	672.83K	0.80%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 16, 2025	BERGER FRANKLIN M	-	Buy	$33.61K
Jan 15, 2025	BERGER FRANKLIN M	-	Buy	$47.88K
Jan 16, 2025	BERGER FRANKLIN M	-	Sell	$33.61K
Jan 15, 2025	BERGER FRANKLIN M	-	Sell	$47.88K
Dec 10, 2024	BERGER FRANKLIN M	-	Sell	$1.02M

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	4	-
2024 Q4	-	1
2024 Q3	-	3
2024 Q2	-	2
2024 Q1	-	6

AVIR Ownership FAQ

Who Owns Atea Pharmaceuticals?

Atea Pharmaceuticals shareholders are primarily institutional investors at 66.55%, followed by 9.99% insiders and 23.46% retail investors. The average institutional ownership in Atea Pharmaceuticals's industry, Biotech Stocks , is 69.02%, which Atea Pharmaceuticals falls below.

Who owns the most shares of Atea Pharmaceuticals?

Atea Pharmaceuticals’s largest shareholders are Blackrock (9.12M shares, 10.87%), Blackrock funding, inc. /de (9.06M shares, 10.73%), and Bml capital management (7.61M shares, 9.01%). Together, they hold 30.62% of Atea Pharmaceuticals’s total shares outstanding.

Does Blackrock own Atea Pharmaceuticals?

Yes, BlackRock owns 10.87% of Atea Pharmaceuticals, totaling 9.12M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 30.19M$. In the last quarter, BlackRock decreased its holdings by -123K shares, a -1.33% change.

Who is Atea Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bml capital management is Atea Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 15.83% of its assets in 7.61M Atea Pharmaceuticals shares, valued at 25.49M$.

Who is the top mutual fund holder of Atea Pharmaceuticals shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Atea Pharmaceuticals shares, with 4.56% of its total shares outstanding invested in 3.85M Atea Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools